National Numbers (as of 21/12/2022)
Malaysia’s total confirmed cases is 95,327 with 16,496 active cases (those who carry high transmission risks) and total death toll of 438.
Malaysia COVID 19 Vaccine Status
The Malaysian government has reached an agreement with AstraZeneca, a research-based biopharmaceutical company, to secure 6.4 million doses or 10 per cent more vaccines.
In addition, through the Health Ministry, the government has also signed a purchasing agreement with Pfizer to obtain 12.8 million doses of its Covid-19 vaccine to meet the immunisation needs of 20% or 6.4 million Malaysians.
The total supply of vaccine is able to cater up to 40 per cent of the population via the agreements with the Covax Facility, Pfizer and AstraZeneca.
The Malaysian government is also in the final stage of negotiations with Sinovac, CanSino and Gamaleya to secure vaccine supply increase of more than 80 per cent of the country’s population or 26.5 million doses.
MY E.G. Services Bhd (MYEG) has entered into a cooperation with Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (“Zhifei”) to get halal certification for the Chinese biopharma company’s Covid-19 vaccine.
The co-operation will also allow MYEG to exclusively distribute the vaccine in Malaysia for a 3-year period.
JAKIM’s Halal accreditation will ensure increased acceptance of the vaccine among the global Muslim population.
Zhifei is presently one of five Chinese companies conducting Phase 3 clinical trials of their COVID-19 vaccines in various parts of the world.
What are the different kinds of vaccines?
RNA – RNA vaccines work by introducing an mRNA sequence ( the molecule which tells cells what to build) to the system which is coded for a specific antigen.
DNA – Short for deoxyribonuscleic acid, DNA is another of the crucial macromolecules for life. A DNA vaccine involves the direct introduction into appropriate tissues of a plasmid – a double straded molecule which exists in bacterial cells.
Viral Vector – Vaccines use live viruses to carry DNA into human cells.
Virus-like particle – This type of vaccine contains molecules that mimic the virus but are not infectious and therefore, not a danger. VLP has been an effective way of creating vaccines against diseases such as human papillomavirus (HPV), hepatitis and malaria.
Protein sub-unit – This kind of vaccine uses a part of the virus, in this case the protein componenet. These vaccines can also be used on almost anyone, including people with weakened immune systems and long term health problems.
Inactivated virus – These vaccine use the dead version of the virus that causes a disease.
According to the World Health Organization (WHO), there are more than 150 vaccines under development for COVID-19. All use a different approach to the vaccine.
When will the vaccine be available to the public?
All vaccines are subject to a 90 – 120 working days timeline for COVID-19 vaccine registration with the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health, Malaysia.
The government is expected to get and administer the first supply of one million vaccines from Pfizer to the target groups as early as February 2021.
How much will it cost?
All COVID-19 vaccines will be provided free for all Malaysian citizens (estimated 32 million population) by the Malaysian government.